Retractable Technologies INC

Retractable Technologies, Inc. announced the declaration of dividends for its Series II and Series III Class B Convertible Preferred Stock, totaling $57,611.25 for the second quarter of 2026.

Retractable Technologies reports a $7.2 million net sales figure and a $6.2 million operating loss for the first quarter of 2026.

Retractable Technologies, Inc. reported the results of its Annual Meeting of Shareholders held on May 8, 2026, where all nominated directors were elected.

Retractable Technologies, Inc. announced a 15.8% increase in 2025 revenues to $38.3 million, alongside a declared dividend for preferred shareholders.

Retractable Technologies, Inc. announced dividends for its Series II and Series III Class B Convertible Preferred Stock shareholders.

Retractable Technologies, Inc. announced its third quarter and year-to-date financial results, alongside receiving an Innovative Technology designation from Vizient for its EasyPoint Blood Collection Tube Holder with Needle.

Retractable Technologies Inc. reported a wider net loss for the first quarter of 2026, with sales declining year-over-year, though international sales saw a significant increase.

Retractable Technologies, Inc. reported a net profit of $0.37 million for Q3 2025, a significant improvement from a loss in the prior year, despite ongoing tariff impacts and strategic shifts to domestic manufacturing.

Retractable Technologies reported a significant increase in Q2 and H1 2025 sales, but faced negative gross profit margins due to tariffs and domestic production costs, partially offset by a litigation settlement.

Retractable Technologies, Inc. reports a net loss for Q1 2025, impacted by tariffs, unrealized losses on investments, and increased domestic production costs.

Retractable Technologies experienced a net loss in Q3 2024, impacted by increased costs and new tariffs, despite a rise in unit sales.

Retractable Technologies experienced a significant net loss in the second quarter of 2024, impacted by decreased sales, an unrealized loss on investments, and a substantial increase in the valuation allowance for deferred tax assets.

Retractable Technologies, Inc. reported a net loss of $12.57 million for fiscal year 2025, impacted by significant tariffs on Chinese imports and material weaknesses in internal controls, despite increased domestic and international sales.

Retractable Technologies' 2024 results were negatively impacted by tariffs on Chinese imports, leading to a gross loss and concerns about internal control over financial reporting.

Retractable Technologies, Inc. reports a decrease in revenue for fiscal year 2023, primarily due to reduced government sales and excess customer inventory, despite increased domestic unit sales in the latter part of the year.

Retractable Technologies Inc. CEO Thomas J. Shaw acquired 5,731 shares of common stock at $0.772 per share through a pre-arranged 10b5-1 plan.

Retractable Technologies Inc. CEO Thomas J. Shaw acquired 100 shares of common stock at $0.8111 per share, executed under a 10b5-1 plan.

Retractable Technologies CEO Thomas J. Shaw acquired 7,500 shares of common stock at a weighted average price of $0.826 per share, increasing his beneficial ownership.

Retractable Technologies CEO Thomas J. Shaw acquired 15,000 shares of common stock at a weighted average price of $0.861, increasing his direct beneficial ownership.

Retractable Technologies Inc. CEO Thomas J. Shaw acquired 35,000 shares of common stock at $0.9151 per share under a pre-arranged 10b5-1 plan.

Retractable Technologies CEO Thomas J. Shaw acquired 34,506 shares of common stock at a weighted average price of $0.9425 per share, executed under a Rule 10b5-1 plan.

Retractable Technologies, Inc. announced its 2026 Annual Meeting of Shareholders to elect three Class 2 Directors and provided updates on corporate governance, executive compensation, and related party transactions.

Retractable Technologies, Inc. sets date for its 2025 Annual Meeting and provides instructions for shareholders to vote on key proposals.

Retractable Technologies, Inc. will hold its 2025 virtual Annual Meeting on May 9, 2025, to vote on the election of three Class 1 Directors, an advisory vote on executive compensation, and an advisory vote on the frequency of executive compensation advisory votes.

Retractable Technologies, Inc. is holding its annual meeting on May 10, 2024, and has made proxy materials available to shareholders.

Retractable Technologies, Inc. will hold its 2024 virtual Annual Meeting of Shareholders on May 10, 2024, to elect three Class 2 Directors.

Thomas J. Shaw, a significant shareholder, increased his beneficial ownership in Retractable Technologies, Inc. to 55.0% through recent open market purchases.

Thomas J. Shaw, a significant shareholder, has increased his beneficial ownership in Retractable Technologies Inc. to 53.3% through a Rule 10b5-1 trading plan, executing multiple purchases in early 2025.